| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/04/2008 | US20080213384 Spherical; react natural cyclodextrins with diphenyl carbonates as crosslinkers in the absence of a solvent by sonication; carrier of active ingredients, pharmaceuticals, food, cosmetic, phytopharmaceuticals; decontaminate polychlorobiphenyls, chlorinated and aromatic organic solvents |
| 09/04/2008 | US20080213378 Atorvastatin; lovastatin; a keto analog of mevinolin; pravastatin; simvastatin; velostatin; fluindostatin; cetyl pyridinium, polymer, biopolymer surface stabilizers; suspensions, gels, aerosols, ointments, creams, controlled release; oral, pulmonary, rectal, opthalmic; improved pharmacokinetic profiles |
| 09/04/2008 | US20080213360 Dry granulation binders, products, and use thereof |
| 09/04/2008 | US20080213355 Polymer shell is biodegradable polylactide, polyglycolide; therapeutic drug and gas dissolved in solvent; drug released from shell by ultrasound rupture of shell; form shell by drop-by-drop emulsification; inkjet printing, cross-flow emulsification; remove solvent from emulsion by agitation, extraction |
| 09/04/2008 | US20080213353 Liposomes encapsulate active agent; vehicles for the delivery of drugs and active agents as well as in the field of gene transfer; delayed, sustained or prolonged release, gradual release, timed release, pH dependent release |
| 09/04/2008 | US20080213351 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 09/04/2008 | US20080213340 Alzheimer's prevention oral vaccines; inserting expression vector into agrobacterium and culturing |
| 09/04/2008 | US20080213338 Implant stent with a retinoid for improved biocompatibility |
| 09/04/2008 | US20080213337 Ceramic powder having hydraulic nonhydrated calcium aluminate and/or calcium silicate microstructure phase; safe controlled release |
| 09/04/2008 | US20080213335 Biocompatible, purified, collagen based matrices from submucosa tissue; such as swine small intestine removal and endotoxin decontamination; tissue defect and/or wound healing components |
| 09/04/2008 | US20080213334 Polyelectrolyte media for bioactive agent delivery |
| 09/04/2008 | US20080213330 Pharmaceutical Compositions Comprising Polyethylene Glycol Having a Molecular Weight of Less Than 600 Daltons |
| 09/04/2008 | US20080213315 free of non-300 kD botulinum toxin type A complexes |
| 09/04/2008 | US20080213311 Neuropeptide Y, kyotorphin, calcitonin-gene related peptides bind receptors; Clostridial toxin HN domain translocates toxin light chain across endosome membrane;Clostridial toxin light chain cleaves a neurosecretory protein; HC domain modified to reduce binding to receptors at neuromuscular junction |
| 09/04/2008 | US20080213310 Use of lytic toxins and toxin conjugates |
| 09/04/2008 | US20080213289 Recombinant anti-cd30 antibodies and uses thereof |
| 09/04/2008 | US20080213223 Using virus-ligand complex to specifically bind and target cancer cells for destruction; gene therapy |
| 09/04/2008 | US20080213177 Nanoparticles Comprising Rna Ligands |
| 09/04/2008 | US20080213176 Labelled peptide; an amino acid sequence of at least 7 amino acids, comprising a mid-part having a lysine residue, and terminal parts comprising consecutive glycine residues |
| 09/04/2008 | DE102007011606A1 Fiber-tangled structure useful as cell settling material, wound covering, medical implant and carriers for pharmaceutical active substance and for producing depot medicament, comprises fibers made of partially interlaced gelatin material |
| 09/04/2008 | CA2686840A1 Liposome for induction of cell-mediated immunity |
| 09/04/2008 | CA2685231A1 Breakthrough pain management |
| 09/04/2008 | CA2679448A1 Methods and compositions for normalizing meibomian gland secretions |
| 09/04/2008 | CA2679420A1 Personal care product comprising cyclodextrin as fragrance-complexing material |
| 09/03/2008 | EP1964855A1 Mineral absorption enhancer, food and feeding stuff |
| 09/03/2008 | EP1964849A2 Transfection complexes |
| 09/03/2008 | EP1964578A2 Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase |
| 09/03/2008 | EP1964577A2 Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase |
| 09/03/2008 | EP1964576A1 Aqueous disinfectant gel preparation |
| 09/03/2008 | EP1964566A1 Preparation with improved bioabsorbability of sapropterin hydrochloride |
| 09/03/2008 | EP1964564A1 Breakthrough Pain Management |
| 09/03/2008 | EP1964549A1 Orally disintegrating tablet comprising fat-soluble substance |
| 09/03/2008 | EP1964548A1 Pharmaceutical compositions comprising a calcilytic agent |
| 09/03/2008 | EP1964547A1 Adhesive topical composition having a barrier action on aphthous ulcers of the oral mucosa |
| 09/03/2008 | EP1963520A1 Method for monitoring and promoting the nutrition and well-being of an animal and/or a human being as well as the productivity of animals |
| 09/03/2008 | EP1963372A2 Anti-mn antibodies and methods of using same |
| 09/03/2008 | EP1963343A1 Polypeptide protracting tags |
| 09/03/2008 | EP1962908A2 Use of polyvinyl lactam-polyoxyalkylene block copolymers as solubilisers for poorly water-soluble compounds |
| 09/03/2008 | EP1962907A2 Protein formulations with reduced viscosity and uses thereof |
| 09/03/2008 | EP1962904A2 Composition comprising an antigen-recognizing molecule and a lipid-based carrier |
| 09/03/2008 | EP1962886A2 Stable protein formulations |
| 09/03/2008 | EP1962870A2 Novel hydrogels and uses thereof |
| 09/03/2008 | EP1962845A2 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
| 09/03/2008 | EP1962833A2 Photoactivatable antimicrobial agents |
| 09/03/2008 | EP1962827A2 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 09/03/2008 | EP1962825A2 Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage |
| 09/03/2008 | EP1962807A1 Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions |
| 09/03/2008 | EP1962806A1 Pre-compacted calcium-containing compositions |
| 09/03/2008 | EP1962802A1 Medicinal composition with active ingredients and wound contact layer with a composition |
| 09/03/2008 | EP1962801A1 Medicinal composition and wound contact layer comprising a composition |
| 09/03/2008 | EP1962800A1 Antimicrobial wound contact layer |
| 09/03/2008 | EP1962799A2 Transdermal administration of active agents for systemic effect |
| 09/03/2008 | EP1962797A1 Powder compositions for inhalation |
| 09/03/2008 | EP1962795A1 Topical compositions for paediatric use |
| 09/03/2008 | EP1962794A2 Long acting injectable parasiticidal formulations |
| 09/03/2008 | EP1962780A1 Aqueous-alcoholic depigmenting gel |
| 09/03/2008 | EP1962598A2 Homogeneous paste formulations |
| 09/03/2008 | EP1694362A4 Improved parasiticide composition |
| 09/03/2008 | EP1604659B1 Tablet containing water-absorbing amino acid |
| 09/03/2008 | EP1545516B1 Topical formulation comprising at least 10% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 09/03/2008 | EP1545500A4 Paclitaxel composition for the intravesical treatment of bladder tumor and preparation method thereof |
| 09/03/2008 | EP1509200B1 Film-shaped, dissolvable preparations for active substance release and method for the production thereof |
| 09/03/2008 | EP1496871B1 Polysaccharide capsules and methods of preparation |
| 09/03/2008 | EP1448234B1 Formulations comprising a cephalosporin compound and their use in treating bacterial infections in cats and dogs |
| 09/03/2008 | EP1431347B1 Composition containing fine particles as carriers for biologically active substance and method for preparing these |
| 09/03/2008 | EP1389094B1 Delivery of sedative-hypnotics trough an inhalation route |
| 09/03/2008 | EP1363617B1 Cyanoacrylate compositions for therapeutic treatment of wounds requiring revision |
| 09/03/2008 | EP1253943B1 Photodynamic therapy for treating conditions of the eye |
| 09/03/2008 | EP1131070B1 Pharmaceutical composition for modified release of an insulin sensitiser and metformin |
| 09/03/2008 | EP1044687B1 Powders containing tocotrienols and tablets prepared by compression molding the same |
| 09/03/2008 | CN101258166A Antibody combining with STEAP-1 protein and deriving molecule thereof |
| 09/03/2008 | CN101258162A Fusion protein of antibody L19 against fibronectin ED-B and interleukin 12 |
| 09/03/2008 | CN101257929A Gentisic acid for stabilisig 123-i radiopharmaceuticals |
| 09/03/2008 | CN101257927A Peptide conjugate for oral delivery of hydrophilic peptide analgesics |
| 09/03/2008 | CN101257926A Conjugates of a G-CSF moiety and a polymer |
| 09/03/2008 | CN101257925A Low-toxicity, long-circulating chimeras of human interferon-alpha analogs and interferon tau |
| 09/03/2008 | CN101257924A Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| 09/03/2008 | CN101257892A Colonic delivery of adsorbents |
| 09/03/2008 | CN101257890A Argatroban formulation comprising an acid as solubilizer |
| 09/03/2008 | CN101257861A Methods and compositions for enhancing vascular access |
| 09/03/2008 | CN101255235A Thermo-sensitive tri-block copolymer having sol-gel conversion characteristic and preparation thereof |
| 09/03/2008 | CN101255234A Thermo-sensitive tri-block polymer as well as preparation method and use thereof |
| 09/03/2008 | CN101255222A P(LA-MAA-EG) degradable pH responsive water gel copolymer |
| 09/03/2008 | CN101254309A Folacin receptor mediated targeted acetyl pullulan polysaccharide nano granule and preparation thereof |
| 09/03/2008 | CN101254308A Biogastrone acid-polyethyleneglycol /chitosan liver target composite drug administration system and preparation thereof |
| 09/03/2008 | CN101254307A Medicament carrying microballoons of hydrophobic nature medicament and method of preparing the same |
| 09/03/2008 | CN101254306A Drug containing adhesive preparation |
| 09/03/2008 | CN101254303A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 09/03/2008 | CN101254302A Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 09/03/2008 | CN101254298A Hoarfrost agent for antioxidation and improving human body immunity and method of preparing the same |
| 09/03/2008 | CN101254288A Applications of Chinese medicinal composition for curing colpitis medicament |
| 09/03/2008 | CN101254270A External use traditional Chinese medicine preparation for curing gynecology inflammation and method of preparing the same |
| 09/03/2008 | CN101254258A Chuanwang anti-inflammation dispersible tablet and method of preparing the same |
| 09/03/2008 | CN101254246A External-used burn and scald treating medicine and its preparation |
| 09/03/2008 | CN101254237A Preparation of pharmaceutical combination enteric soft capsules containing eucalyptol, limonene and a-pinene |
| 09/03/2008 | CN101254235A Extract for curing periodontal diseases and method of preparing the same |
| 09/03/2008 | CN101254231A Preparation for curing perennial allergic rhinitis external-use traditional Chinese medicine preparation |
| 09/03/2008 | CN101254230A Shuxiong dropping pill. and method of preparing the same |
| 09/03/2008 | CN101254215A Preparing method of Chinese medicine catablasm base material |
| 09/03/2008 | CN101254214A Chinese medicine catablasm base material |